Stockreport

FDA Accepts GSK's BLA for Blenrep Combos in Multiple Myeloma [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF The BLA seeks the approval of Blenrep in combination with J&J's Velcade (bortezomib) plus dexamethasone (BorDex) or Bristol Myers' Pomalyst (pomalidomide) plus dexameth [Read more]